Alimera Sciences investor relations material

Alimera Sciences is a pharmaceutical company that develops and commercializes ophthalmic pharmaceuticals. We market ILUVEN, an intravitreal implant for the treatment of diabetic macular edema (DME) which is a disease of the retina that affects individuals with diabetes and leads to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. Our products can be purchased directly from our website or through authorized distributors. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.